A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

计划入组 54 人 · 首次发布于 2025 年 1 月 23 日

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

计划入组 5 人 · 首次发布于 2025 年 12 月 5 日

Wearable Dark-adaptometer in Normal Adult Healthy Volunteers

计划入组 20 人 · 首次发布于 2016 年 2 月 4 日

photoreceptor rescue cell therapy

Photoreceptor cell therapy (BlueRock)

PNC-1

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

Southcoast Center For Primary & Specialty Care

United States

BlueRock Therapeutics' OpCT-001 Receives FDA Clearance for Phase I/IIa Trial in Primary Photoreceptor Diseases

FDA Grants Fast Track Status to BlueRock's Novel Cell Therapy for Inherited Retinal Diseases

OMEICOS' OMT-28 Heads Directly to Pivotal Phase 3 in Primary Mitochondrial Diseases Following FDA Endorsement